Agilent Technologies Instrumentation — Net revenue increased by 0.8% to $658.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from $625.00M to $658.00M. Over 4 years (FY 2021 to FY 2025), Instrumentation — Net revenue shows relatively stable performance with a -2.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong demand for new capital equipment and successful product innovation, while a decrease may indicate market saturation, budget constraints among research customers, or a shift toward service-based revenue models.
This metric represents the total gross sales generated from the sale of analytical instruments and hardware systems with...
Comparable to 'Instrument Sales' or 'Equipment Revenue' reported by other life science and analytical technology peers, often evaluated alongside service and consumable revenue to determine the overall health of the installed base.
a_segment_instrumentation_net_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $632.00M | $640.00M | $704.00M | $691.00M | $646.00M | $737.00M | $833.00M | $759.00M | $689.00M | $643.00M | $651.00M | $630.00M | $548.00M | $556.00M | $620.00M | $625.00M | $550.00M | $599.00M | $653.00M | $658.00M |
| QoQ Change | — | +1.3% | +10.0% | -1.8% | -6.5% | +14.1% | +13.0% | -8.9% | -9.2% | -6.7% | +1.2% | -3.2% | -13.0% | +1.5% | +11.5% | +0.8% | -12.0% | +8.9% | +9.0% | +0.8% |
| YoY Change | — | — | — | — | +2.2% | +15.2% | +18.3% | +9.8% | +6.7% | -12.8% | -21.8% | -17.0% | -20.5% | -13.5% | -4.8% | -0.8% | +0.4% | +7.7% | +5.3% | +5.3% |